Garber, A J

The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man.

Garber, A. J., Cryer, P. E., Santiago, J. V., Haymond, M. W., Pagliara, A. S., & Kipnis, D. M. (1976) · Journal of Clinical Investigation

Diabetes Management and ResearchPancreatic function and diabetes

Cited by 351

Weight loss with liraglutide, a once‐daily human glucagon‐like peptide‐1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue

Jendle, J., Nauck, M. A., Matthews, D. R., Frid, A., Hermansen, K., Düring, M., Zdravkovic, M., Strauss, B. J., Garber, A. J., & Groups, O. B. O. T. L. A. L. S. (2009) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 312

Alanine and glutamine synthesis and release from skeletal muscle. IV. beta-Adrenergic inhibition of amino acid release.

Garber, A. J., Karl, I. E., & Kipnis, D. M. (1976) · Journal of Biological Chemistry

Muscle metabolism and nutritionAmino Acid Enzymes and Metabolism

Cited by 152

Treat-to-target trials: uses, interpretation and review of concepts

Garber, A. J. (2014) · Diabetes, Obesity and Metabolism

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 94

Reductions in lipids and CV risk markers in patients with type 2 diabetes treated with liraglutide: a meta-analysis

Plutzky, J., Garber, A., Falahati, A., Toft, A. D., & Poulter, N. R. (2009) · Canadian Journal of Diabetes

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 33